CCHT(000661) 中证网·2025-04-21 05:15Core Viewpoint - Changchun High-tech's 2024 annual report highlights a significant increase in R&D investment, reflecting the company's strategic shift towards diversified innovation and long-term growth [1][4]. Group 1: R&D Investment - In 2024, the company's R&D investment reached 2.69 billion yuan, an increase of 11.20% year-on-year, with R&D expenses amounting to 2.17 billion yuan, up 25.75% [1]. - R&D investment accounted for 19.97% of the company's operating revenue, indicating a strong commitment to innovation [1]. Group 2: Strategic Transformation - The company aims to break away from reliance on a single product and is focusing on a diversified innovation strategy to enhance its product pipeline [1]. - Changchun High-tech is actively seeking to enrich its innovation pipeline and accelerate the commercialization of its research outcomes [1]. Group 3: Product Development - Changchun High-tech has made significant breakthroughs in the development of innovative products, including new treatments in the reproductive health sector and long-acting growth hormones for specific conditions [3]. - The company has 24 key products with 28 indications currently in clinical stages, including 9 first-class innovative drugs, which could provide a solid foundation for high-quality growth [3]. Group 4: Subsidiary Focus - Jinsai Pharmaceutical, a core subsidiary of Changchun High-tech, is focusing on innovation and diversification to mitigate the impact of market fluctuations from single product reliance [2]. - Jinsai Pharmaceutical is expanding its strategic focus from children's growth to comprehensive management of children's health and women's health, developing a diverse product matrix across various therapeutic areas [2]. Group 5: Future Outlook - The company plans to enhance its R&D investment while ensuring stable performance, aiming for a comprehensive pipeline layout and global expansion [4]. - There is a focus on upgrading existing product technologies and optimizing processes to meet market demands with new products [4].